Business Wire

TRIGO-GROUP

4.11.2015 09:01:24 CET | Business Wire | Press release

Share
TRIGO and PIC to Join Forces

The TRIGO Group, an international provider of operational quality solutions headquartered in Paris, France, and The PIC Group, a North American leader of 3 rd party quality solutions, have joined forces. The PIC Group, headquartered out of Ontario Canada with locations in Canada, USA, and Mexico, has been servicing the automotive and manufacturing industries for over 30 years. The merger between the two companies will create the largest and most comprehensive breadth of quality services being offered globally in the market today.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151104005141/en/

As these two market leaders merge, a single global provider of quality services will be created with geographic coverage second to none. With over $230 Million in annual sales, a strong financial balance sheet, and a seasoned workforce recognized for their know-how and expertise in quality systems and controls, they are well positioned to dominate the marketplace internationally. Their global network of ~7000 quality professionals across 20 countries worldwide is impressive. This creates a unique value proposition, allowing leading manufacturers the ability to secure their quality performance all along the supply chain. Combine this expertise with the utilization of state-of-the-art technology, and a powerhouse of quality services has emerged.

A merger of this magnitude will be most welcome by manufacturers worldwide. With the ongoing globalization of supply chains and manufacturing footprints within the automotive and aerospace industries, also comes a requirement to provide global resources and support at a higher level than ever before. The merger between TRIGO and PIC will ensure that the highest level of quality performance is achieved at every step of the supply chain, enabling manufacturers to meet even the most demanding quality requirements. With a comprehensive portfolio of quality services and their distinct ability to design, create, and implement customized solutions, customers can turn to TRIGO–PIC to receive an unmatched level of service and expertise. Manufacturers many now turn to one source globally for all of their quality needs.

“This merger between TRIGO and PIC will enable us to provide global coverage to our clients. With the distinctive know-how, expertise, and reputation of PIC in North America, we will be able to expand the delivery of our quality services not only geographically for our existing automotive clients, but also better service for our aerospace customers,” said Matthieu Rambaud, TRIGO Group’s CEO.

“These are exciting times. This merger will benefit our clients immensely as they will now be able to source one provider to meet their quality needs globally. In addition, given TRIGO’s expertise in aerospace, North American aerospace manufacturers now have a high level solution provider to assist in meeting their stringent quality requirements. A merger of this magnitude will benefit customers and employees alike, taking us to new levels of quality and service,” declared Al Duffy, founder and President of The PIC Group.

Following the acquisitions of Qualitaire in 2012 and Global Q in 2015, this merger with The PIC Group is another milestone in the successful deployment of TRIGO’s “buy-and-build” strategy, supported by IK Investment Partners as majority shareholder since 2011, which aims at building TRIGO as the global leader of quality solutions for the transportation industry.

About The TRIGO Group

Founded in 1997, TRIGO is a multinational company providing Quality Management solutions for the manufacturing sector, particularly within the transportation industries. With annual revenues of ~150 M€ and a team of more than 5000 professionals present in 20 countries, TRIGO offers a comprehensive portfolio of Quality Inspection, Engineering, and Management Services to its customers, including Airbus, PSA, General Motors, Audi Hungaria, Daimler, Robert Bosch, and many other international manufacturers.

For more information, please visit www.trigo -group.com

About The PIC Group

Founded in 1985, The PIC Group first began by offering a variety of training seminars. They quickly grew their business by responding to the needs of their customers with cost effective and innovative quality solutions including Quality Inspection, Engineering, and Training. Today, PIC services the automotive and manufacturing sectors in North America, including many major auto manufacturers and their Tier 1 supply base. PIC employs nearly 2000 quality specialists focused on assisting customers in containing and resolving their quality problems quickly and efficiently by offering both short and long-term solutions.

For more information, please visit www.thepicgroup.com

Contact:

MEDIA CONTACTS
Sibylle Descamps, M. +33 (0)6 82 097 007
CTcom
E. sibylle.descamps@ct-com.com

Social Media:

http://www.facebook.com/trigoqualityallalong/?fref=ts

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Following Oral Presentation of Phase I Data at AACR 2026, Debiopharm Announces FDA Fast Track Designation for Lunresertib in Combination With Zedoresertib for Genomic-Defined Platinum-Resistant Ovarian Cancer20.4.2026 14:30:00 CEST | Press release

Debiopharm (www.debiopharm.com), a privately-owned, Swiss-based biopharmaceutical company aiming to establish tomorrow’s standard of care to cure cancer and infectious diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to the combination of its PKMYT1 inhibitor, lunresertib (Debio2513), and its WEE1 inhibitor, zedoresertib (Debio 0123). The designation is for the treatment of adult patients with CCNE1 amplified, or a deleterious mutation in either FBXW7 or PPP2R1A, platinum-resistant/refractory ovarian cancer. The FDA’s Fast Track program is designed to facilitate the development and expedite the review of new drugs intended to treat serious conditions and fill an unmet medical need. Programs granted Fast Track designation benefit from more frequent communication with the FDA and, if relevant criteria are met, may be eligible for Priority Review and Accelerated Approval of a New Drug Application (NDA). Momentum Following AACR O

Data4Industry-X Empowers Industrial Organizations in Meeting Digital Product Passport Requirements20.4.2026 14:17:00 CEST | Press release

Contributing to the International Manufacturing-X Council Showcase at Hannover Messe, to improve resilience, productivity and innovation in Manufacturing Hannover Messe - Data4Industry-X, the trusted industry data space solution, builds its momentum by accelerating Digital Product Passport (DPP) compliance with trusted, secure and traceable data exchange at scale, as demonstrated at Hannover Messe April 20-24, 2026 . As theDigital Product Passport becomes a regulatory reality for manufacturing organizations, the ability to exchange data in a trusted, secure and traceable environment across the entire supply chain, in compliance with data regulations such as the Data Act, has become critical. Actively contributing to the International Manufacturing-X Council showcase, driven by LNI 4.0 association involving 16 countries, Data4Industry-X, a decentralized environment, demonstrates the use case of the DPP on the battery’s State of Health, and how the battery current capacity and performanc

Ushio Industry & Entertainment Appoints Takuya Matsumoto as President & CEO and Outlines Strategic Direction for the Next Phase20.4.2026 12:32:00 CEST | Press release

Ushio Industry & Entertainment (Ushio INE GmbH) announces the appointment of Takuya Matsumoto as President and Chief Executive Officer, marking a key milestone in the evolution of the business and its integration within the Ushio Group. With more than 20 years of experience across sales, new business development, and global operations, Takuya Matsumoto brings deep industry expertise and a strong leadership track record within Ushio. Most recently, he served as General Manager of the Global Business Unit, where he played a pivotal role in advancing global growth initiatives. A Clear Vision: A strong heritage with a forward-looking vision focused on innovation, operational excellence, and customer value Under Takuya Matsumoto’s leadership, Ushio INE will continue to build on its strong legacy while advancing its mission to deliver high-performance, high-quality lighting solutions across industrial and entertainment markets worldwide. “Our mission is to continuously deliver essential ligh

Compass Pathways to Participate in Needham Virtual Psychedelics Forum on April 27, 202620.4.2026 12:30:00 CEST | Press release

Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that CEO Kabir Nath will participate in a panel entitled “Clinical Risk, Regulatory Reality and the Path to Scale” at the Needham Virtual Psychedelics Forum on April 27, 2026, at 11am-12pm ET. A live audio webcast of this event will be accessible from the “Events” page of the Investors section of the Compass website. A replay of the webcast will be accessible for 30 days following each event. About Compass Pathways Compass Pathways plc (Nasdaq: CMPS) is a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. We are motivated by the need to find better ways to help and empower people with serious mental health conditions who are not helped by existing treatments. We are pioneering a new paradigm for treating mental health conditions focused on rapid and durable response

PPG invests in testing line for radiation-curable coatings at Marly, France20.4.2026 11:00:00 CEST | Press release

Installation helps accelerate development cycles, reduce number of customer trials PPG (NYSE: PPG) today announced the installation of an advanced testing line for radiation-curable coatings at its R&D Center of Excellence in Marly, France. The line can test multiple curing technologies, including infrared (IR), ultraviolet (LED, excimer and arc lamps), and electron beam (EB). This investment allows the company to accurately replicate customer production conditions, helping accelerate development cycles and reduce the number of customer trials. Unlike conventional thermal curing, radiation curing requires less energy because it operates at or near ambient temperature. This reduction in energy demand can significantly lower carbon emissions by 65%*, with further gains possible when powered by renewable energy sources. In addition, UV- and EB-curable systems typically use 100% solids formulations with no solvents, reducing or eliminating volatile organic compound emissions. Beyond sustai

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye